Latest Headlines

  1. Ensorcell Launches Versaweld™ Precision Tube Welding Platform At INTERPHEX 2026 4/10/2026
  2. Anixa Biosciences Advances Breast Cancer Vaccine Toward Phase 2 With Selection Of Cytovance Biologics For Cgmp Manufacturing 4/10/2026
  3. Symbiosis Expands Commercial Capabilities With Addition Of New Stability Chamber 4/1/2026

    Symbiosis Pharmaceutical Services (Symbiosis), a Contract Development and Manufacturing Organisation (CDMO) specialising in the sterile GMP manufacturer of injectable drug products, has expanded its Quality Control (QC) laboratory with the installation of a new 30°C stability chamber.

  4. Samsung Biologics Completes Acquisition Of GSK's Manufacturing Facility In Rockville, Maryland 3/31/2026

    Samsung Biologics (KRX: 207940.KS), a leading contract development and manufacturing organization (CDMO), today announced the completion of its acquisition of a manufacturing facility in Rockville, Maryland from GSK, establishing the company's first manufacturing presence in the United States.

  5. Gore Expands Leadership In Membrane Chromatography With Next-Generation Affinity Solutions 3/31/2026
  6. Lonza Launches Media Development Lab In Singapore For Cell Culture Media Optimization 3/26/2026

    Lonza, one of the world’s largest contract development and manufacturing organizations (CDMOs), today announced the launch of its Media Development Lab at its Singapore site.

  7. UCB Announces New Biologics Manufacturing Facility Investment In Georgia 3/25/2026

    The State of Georgia, Gwinnett County and the Rowen Foundation today announced that global biopharmaceutical company UCB has selected Rowen as the site of its new U.S. biologics manufacturing campus. The planned project represents a direct investment of approximately $2 billion and is expected to create more than 330 high-quality jobs as the facility comes online over the next several years.

  8. Asimov Launches RNA Edge, A Lab-In-The-Loop Platform For AI Optimization Of RNA Therapeutic Candidates 3/19/2026

    Asimov, the synthetic biology company advancing the design and manufacture of therapeutics, announces the launch of its RNA Edge System, an integrated AI, synthetic biology, and laboratory platform to optimize RNA therapies.

  9. Abzena Recognized As A Market-Leading Antibody-Drug Conjugate CDMO In Frost & Sullivan Radar Report 3/18/2026

    Abzena, the leading end-to-end integrated CDMO for complex biologics and bioconjugates, today announced it has been named a leader in the Frost Radar™ Report for Antibody Drug Conjugate Contract Development and Manufacturing Organizations.

  10. CEO Insights And Trends: The Future Of The Sterile Filling CDMO Industry 3/17/2026

    Denis Johnson, CEO, explores developments in the CDMO sector and reveals how GRAM is gearing up for its latest phase of growth in sterile filling.